A novel predictive model for posttransplant lymphoproliferative disorder in the letermovir prophylaxis era (ASH 2025) - Nov 4, 2025 - Abstract #abs25-9927; 4269; Pres time: Dec 7, 2025; 06:00 PM - 08:00 PM; Location: OCCC - West Halls B3-B4; "The score model showed acceptablediscrimination, with a C statistic of 0.65 and a relatively good moderate calibration curve (HL test, p =0.74).ConclusionsOur study demonstrates a novel comprehensive model for predicting PTLD in patients undergoingallogeneic hematopoietic stem cell transplantation, in the new context of the wide range of letermoviruse. This model may help clinicians quickly identify patients at high risk of PTLD and take correspondingprevention and treatment measures."
Post-transplantation • Predictive model • Acute Graft versus Host Disease • Anemia • Aplastic Anemia • Bone Marrow Transplantation • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Fibrosis • Genetic Disorders • Graft versus Host Disease • Hematological Disorders • Immunology • Infectious Disease • Metabolic Disorders • Ocular Inflammation • Ophthalmology • Pneumonia • Respiratory Diseases • Retinal Disorders • Transplantation
|
|
Chen-Cong Wang1; Xuying Pei1; Hai-Xia Fu1; Yuanyuan Zhang1; Xiao-Dong Mo1; Fengrong Wang1; Yuqian Sun1; Meng Lv1; Xiangyu Zhao1; Yuhong Chen1; Yu Wang1; Ying-Jun Chang1; Xiaojun Huang1; Xiaohui Zhang1
|